At C.H. Robinson, Artificial Intelligence Has Now Performed Over 3 Million Shipping Tasks

At C.H. Robinson, Artificial Intelligence Has Now Performed Over 3 Million Shipping Tasks

The global logistics provider has also expanded its fleet of generative AI agents to further automate the lifecycle of a freight shipment

EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–
Today C.H. Robinson announced it has performed over 3 million shipping tasks with its fleet of generative AI agents – proprietary tech tools the global logistics provider has built to automate steps across the lifecycle of a shipment and reduce customers’ speed-to-market from hours to seconds.

“That’s 3 million manual tasks our people didn’t have to do,” said Arun Rajan, Chief Strategy and Innovation Officer. “We’re at well over 1 million price quotes delivered by AI. In March, we hit 1 million orders processed by AI. Those are two of our most mature generative AI agents, and they’re more capable every day as the models we’ve built get smarter and as we apply them to more of our 83,000 customers. Each additional shipping step we’ve automated beyond those has created new leaps in efficiency for global supply chains and freed our people to do more high-value work for our customers.”

As one of the world’s largest logistics providers, C.H. Robinson has been using artificial intelligence at scale for more than a decade – going back to its pioneering freight-matching capabilities and continuing today through its supply chain insights, optimization and visibility. With the newest and most powerful form of AI, the company broke a long-standing barrier to automation in 2023 and announced its first generative AI agents throughout 2024. So far in 2025, data from C.H. Robinson’s 37 million shipments a year and from its supply chain experts have enabled the company to create new AI models, build new AI agents and rapidly increase the impact of its existing AI agents.

Now the company is using its exclusive generative AI tech to provide price quotes, process orders, acquire trucking capacity, set appointments for pickup and delivery, check on loads in transit and has taken the first steps to supply tracking updates with generative AI.

“Price quotes for truckload shipments was a natural starting place for our generative AI tech, because we move more truckload freight than anyone in North America,” said Mark Albrecht, VP for Artificial Intelligence. “But we also do more less-than-truckload shipping than any 3PL. Since we added LTL to our quoting agent, every month we’ve had at least a 30% jump in LTL quotes delivered by AI. Our tech that classifies incoming email can even recognize when a shipper is asking for quotes on both truckload and LTL freight.”

LTL has also been a factor in growing the number of emailed load tenders that no longer have to be manually processed and the number of customers who are benefiting.

“In February and March, our AI took care of just as many LTL orders as truckload orders,” Albrecht said. “We first applied our orders AI agent to emails from our biggest customers with the most truckload volume. Now in 2025, we’re extending it to more of our customers in the small and medium business sector, who are heavy users of both email and LTL shipping. Instead of waiting up to four hours for a person to get to their shipment in an email queue, over 5,200 customers are getting their loads accepted in under 90 seconds.”

As emails come into C.H. Robinson from carriers offering capacity, a new AI agent launched in January reads them, extracts information about available trucks and feeds the details into the company’s real-time capacity center. In February, the agent uploaded nearly 10 times more trucks to the system.

“Like our other AI agents, the truck posting agent lifts this repetitive manual task off of our people, frees them to do more strategic work and increases speed-to-market for our customers,” Albrecht said. “If a carrier emails us that they’ll have an empty truck Wednesday in Dallas and another Thursday in Chicago, the faster we get that information on system, the faster our load-matching platform notifies the carrier of ideal loads for their backhaul and the faster our customers’ freight hits the road.”

In March, C.H. Robinson’s innovations included

  • Rolling out a new version of its AI agent for appointments, now that the original has already set more than 1 million
  • Adding voice capability to a pilot using generative AI to contact carriers for missing status updates
  • Building an AI model for responding to customer requests for tracking updates

“Generative AI played a key role in the company’s 30% productivity increase across 2023 and 2024,” said Rajan, C.H. Robinson’s Chief Strategy and Innovation Officer. “Greater automation not only makes our operations and our customers’ supply chains more efficient. It lowers our cost to serve while simultaneously raising our quality of service. As we deploy generative AI across more aspects of our business, our teams can spend more of their time on the most complex shipments and the most pressing disruptions and the most valuable supply chain optimizations for our customers. In 2025, we increasingly view generative AI as a growth lever and a critical element of our broader ecosystem of AI capabilities for customers, carriers and the company.”

ABOUT C.H. ROBINSON

C.H. Robinson delivers logistics like no one else™. Companies around the world look to us to reimagine supply chains, advance freight technology and solve logistics challenges—from the simple to the most complex. 83,000 customers and 450,000 contract carriers in our network trust us to manage 37 million shipments and $23 billion in freight annually. Through our unmatched expertise, unrivaled scale and tailored solutions, we ensure the seamless delivery of goods across industries and continents via truckload, less-than-truckload, ocean, air and beyond. As a responsible global citizen, we make supply chains more sustainable and proudly contribute millions to the causes that matter most to our employees. For more information, go to www.chrobinson.com. (Nasdaq: CHRW)

CHRW-IR

Maria Lettman

[email protected]

KEYWORDS: United States North America Minnesota

INDUSTRY KEYWORDS: Other Transport Technology Trucking Rail Maritime Air Transport Logistics/Supply Chain Management Artificial Intelligence

MEDIA:

Logo
Logo

Orbic North America and GCT Semiconductor Sign LOI to Develop and Supply Orbic-Branded FWA Gateway and Mobile Hotspot with GCT’s Verizon-Certified 5G Module

Orbic North America and GCT Semiconductor Sign LOI to Develop and Supply Orbic-Branded FWA Gateway and Mobile Hotspot with GCT’s Verizon-Certified 5G Module

HAUPPAUGE, N.Y. & SAN JOSE, Calif.–(BUSINESS WIRE)–
Orbic North America, LLC (“Orbic”), an international leader in mobile technology innovation, and GCT Semiconductor Holding, Inc. (“GCT”) (NYSE: GCTS), a leading designer and supplier of advanced 5G and 4G semiconductor solutions, today announced the signing of a letter of intent (LOI) for a partnership to jointly develop and supply an Orbic-branded mobile hotspot and FWA gateway utilizing a Verizon-certified 5G module based on GCT’s new 5G chipset. The LOI outlines the framework for collaboration between the parties, including terms related to volume purchases for supply to Verizon and other operators.

As part of the collaborative multi-phase market rollout, Orbic and GCT will initially focus on devices for the Verizon network. Additionally, they will offer versions of the module and devices, including mobile hotspots and CPEs, to other network operators worldwide. GCT will support the joint development and technical efforts by providing core services, including technical expertise, and chipsets for volume production requirements.

“We are thrilled to partner with Orbic, a trusted and established Verizon supplier, to embark on the development and supply of a state-of-the-art 5G module for mobile hotspots and FWA gateways,” says John Schlaefer, CEO of GCT. “This collaboration underscores GCT’s commitment to innovation and delivering cutting-edge 5G technology solutions. As we work together to create a Verizon-certified 5G module, we are confident that the new Orbic-branded devices using the GCT 5G chipset will set new standards for connectivity and performance.”

“By combining Orbic’s cutting-edge 5G device innovation with GCT’s deep expertise in advanced wireless connectivity, we are strengthening our ability to deliver transformative solutions,” said Mike Narula, Founder and CEO of Orbic. “This partnership will not only broaden the reach of our wireless access innovations but also extend the benefits of wireless connectivity without the need for traditional copper connection, all while ensuring exceptional service quality.”

Orbic is building a state-of-the-art manufacturing facility in Hauppauge, NY, which will be utilized for manufacturing CPEs, mobile hotspots, smartphones and tablets.

The partnership contemplated by the LOI is subject to the negotiation of and entry into definitive agreements, and the parties intend to complete this process as soon as practicable.

About Orbic

Orbic, a US-headquartered technology company based in New York, reimagines the connected experience by thinking outside of the mainstream. Using best-in-class technology, Orbic provides meaningful features to customers seeking something unique and accessible to all, without exclusion. As a leader in developing and manufacturing innovative mobile solutions for smart, value-tech consumers, Orbic offers a full portfolio of connected solutions from smartphones and tablets to mobile hotspots and connected laptops. Orbic’s extensive global ecosystem of partners, suppliers, and carriers ensures that their products deliver exceptional value and performance, making high-quality technology accessible to a wider audience. For more information, visit www.orbic.us.

About GCT Semiconductor

GCT is a leading fabless designer and supplier of advanced 5G and 4G LTE semiconductor solutions. GCT’s market-proven solutions have enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, smartphones, etc., for the world’s top wireless carriers. GCT’s system-on-chip solutions integrate radio frequency, baseband modem and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness. For more information, visit www.gctsemi.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1955. These forward-looking statements include, without limitation, statements regarding GCT’s partnership with Orbic and the development of 5G products. Words such as “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside the Company’s control and are difficult to predict. Factors that may cause actual future events to differ materially from the expected results, include, but are not limited to: the ability of the Company to develop its 5G products and generate revenue; the ability of the Company to enter into and meet the obligations under partnership and collaboration agreements; the ability of the Company to grow and manage growth profitability and retain its key employees; the Company’s financial and business performance, including the Company’s financial projections and business metrics; changes in the Company’s strategy, future operations, financial position, estimated revenues and losses, forecasts, projected costs, prospects and plans; the Company’s inability to anticipate the future market demands and future needs of its customers; the impact of component shortages, suppliers’ lack of production capacity, natural disasters or pandemics on the Company’s sourcing operations and supply chain; the Company’s future capital requirements and sources and uses of cash; the ability of the Company to raise sufficient capital to fund its operations; the ability to implement business plans, forecasts, and other expectations, including the growth of the 5G market; the risk that the Company may not be able to repay its debt; the risk of economic downturns that affects the Company’s business operation and financial performance; the risk that the Company may not be able to develop and design its products acceptable to its customers; actual or potential conflicts of interest of the Company’s management with its public stockholders; and other risks and uncertainties indicated from time to time in the Company’s filings with SEC, including the Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and those disclosures under the “Risk Factors” sections therein. The foregoing list of factors is not exhaustive. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Orbic North America, LLC

GCT Semiconductor:

 

KEYWORDS: South Korea United States North America Asia Pacific California New York

INDUSTRY KEYWORDS: Other Manufacturing Mobile/Wireless Technology Semiconductor 5G Carriers and Services Telecommunications Manufacturing Networks Hardware

MEDIA:

Logo
Logo

Cimpress to Host Public Q&A Call Following Q3 FY2025 Earnings Announcement

Cimpress to Host Public Q&A Call Following Q3 FY2025 Earnings Announcement

DUNDALK, Ireland–(BUSINESS WIRE)–
Cimpress plc (Nasdaq: CMPR) announced that it will host a public Q&A call on Thursday, May 1, 2025 at 8:00 am ET following the release of its Q3 FY2025financial results at 4:05 pm ET on Wednesday, April 30, 2025. The live call will be accessible on ir.cimpress.com, and a replay will be available at the same link following the call. We will take live questions on the call via chat, and investors may also presubmit questions any time before 11:00 pm ET on Wednesday, April 30, 2025 by emailing [email protected].

About Cimpress

Cimpress plc (Nasdaq: CMPR) invests in and builds customer-focused, entrepreneurial, print mass-customization businesses for the long term. Mass customization is a competitive strategy which seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Cimpress businesses include BuildASign, druck.at, Drukwerkdeal, easyflyer, Exaprint, National Pen, Packstyle, Pixartprinting, Printi, Tradeprint, VistaPrint, and WIRmachenDRUCK. To learn more, visit cimpress.com.

Cimpress and the Cimpress logo are trademarks of Cimpress plc or its subsidiaries. All other brand and product names appearing on this announcement may be trademarks or registered trademarks of their respective holders.

Investor Relations:

Meredith Burns

[email protected]

Media Relations:

Sara Litwiller

[email protected]

KEYWORDS: Ireland Europe

INDUSTRY KEYWORDS: Online Retail Advertising Retail Communications Other Retail Office Products

MEDIA:

Logo
Logo

Gambling.com Group to Report 2025 First Quarter Results on May 15 and Host Conference Call and Webcast

Gambling.com Group to Report 2025 First Quarter Results on May 15 and Host Conference Call and Webcast

CHARLOTTE, N.C.–(BUSINESS WIRE)–
Gambling.com Group Limited (Nasdaq: GAMB) (“Gambling.com Group” or the “Company”), a fast-growing provider of digital marketing services for the global online gambling industry, today announced it will release its 2025 first quarter results before the market opens on Thursday, May 15, 2025, and host a conference call and simultaneous webcast at 8:00 a.m. ET that day. During the call, Gambling.com Group Chief Executive Officer and Co-founder, Charles Gillespie, and Chief Financial Officer, Elias Mark, will review the Company’s financial results and provide a business update, followed by a question-and-answer session.

Both the call and webcast are open to the public and may include forward-looking information. A replay of the webcast will be archived shortly after the call and can be accessed for approximately 30 days on the Company’s website: www.gambling.com/corporate/investors.

Conference Call / Webcast Details

Date/Time:

Thursday, May 15, 2025, at 8:00 a.m. ET

Webcast:

https://www.webcast-eqs.com/register/Gambling051525/en

U.S. Toll-Free Dial In:

877-407-0890

International Dial In:

+1 201-389-0918

To access the call, please dial in approximately ten minutes before the start of the call.

About Gambling.com Group Limited

Gambling.com Group Limited (Nasdaq: GAMB) (the “Group”) is a fast-growing provider of digital marketing services for the global online gambling industry. Founded in 2006, the Group has offices globally, primarily operating in the United States and Ireland. Through its proprietary technology platform, the Group publishes a portfolio of premier branded websites including Gambling.com, Bookies.com, Casinos.com, and RotoWire.com. Gambling.com Group owns and operates more than 50 websites in more than 10 languages across 19 national markets covering all aspects of the online gambling industry, including iGaming and sports betting, and the fantasy sports industry. The Group’s OddsJam and OpticOdds platforms provide a suite of tools and services to assist consumers and enterprises in sports betting.

For further information, please contact:

Investors:

Peter McGough, Gambling.com Group, [email protected]

or

Richard Land, Norberto Aja, JCIR, [email protected]

KEYWORDS: United States North America North Carolina

INDUSTRY KEYWORDS: Marketing Casino/Gaming Communications Entertainment

MEDIA:

Logo
Logo

Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers

Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers

SmartTrack™ aims to reduce the need for clinical studies in generic drug product approvals

CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announces the commencement of a clinical study to validate its proprietary SmartTrack™ platform. The platform was developed by Aptar’s drug services company, Nanopharm. If validated, SmartTrack™ aims to reduce the need for clinical studies in generic drug product approvals by proving it can accurately predict clinical outcomes – removing a major barrier for pharma companies and regulators and paving the way for wider patient access to medications. This validation would establish SmartTrack™ as a credible in-vitro-in-silico alternative to comparative clinical endpoint (CCEP) studies, and a reliable approach to derisking in vitro-pharmacokinetic (PK) only approaches, specifically for generic inhaled drug products.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250416330741/en/

Nanopharm’s SmartTrack™ for Generic Inhalation Products

Nanopharm’s SmartTrack™ for Generic Inhalation Products

The study, which is expected to begin in Q2 2025, has been carefully designed based on detailed feedback from regulatory agencies to meet the requirements for obtaining a biowaiver of the CCEP for pharmaceutical companies working with Nanopharm as well as enabling the models to provide supportive data to the in vitro studies.

The study will involve radio-labelling three different commercially available pressurized metered-dose inhaler (pMDI) drug products and imaging regional lung deposition.

These results will be compared with regional deposition predictions from computational fluid dynamic (CFD) simulations conducted in collaboration with Fluidda, Medimprove and i2c Pharmaceutical Services.

Additionally, pharmacokinetic (PK) data from subjects will be collected to validate predictions from Nanopharm’s Simhalation™ platform, which uses physiologically based pharmacokinetic (PBPK) modeling.

The resulting study data will be submitted to the U.S. FDA as one of the first Model Master Files (MMF), which would allow multiple companies to benefit from this data when partnering with Aptar, similar to the well-established Drug Master File (DMF) route.

Gael Touya, President, Aptar Pharma, stated, “This clinical study marks a significant milestone in the evolution of Aptar’s offerings. Providing clinically validated data to our pharmaceutical partners and regulatory bodies will be crucial in demonstrating the platform’s viability, which could lead to accelerated approvals and broader access to generic inhaled medicines for more patients.”

In addition to supporting generic Abbreviated New Drug Application (ANDA)1 approvals, the study could also help accelerate and derisk other programs, such as the reformulation of pMDIs with new lower global warming potential (GWP) propellants, novel (drug product) combinations, developing drug products from other dosage forms, and New Chemical Entity (NCE) development into pMDIs.

The study is expected to conclude by the end of 2025. Interested parties are encouraged to contact Nanopharm to explore how this package can support their product development and approval strategies.

About Aptar

Aptar is a global leader in drug and consumer product dosing, dispensing and protection technologies. Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Nanopharm is a leading provider of tailored analytical, modelling and pharmaceutical development services, with a focus on orally inhaled and nasal drug products (OINDP). The company’s unique analytical technologies and formulation development tools enable seamless translation of pre-clinical product development through to CMC, IVBE and cGMP manufacturing and release, whether for generic drug products or new molecular entities. This helps pharmaceutical companies to holistically understand how all properties of the combination drug products influence product functionality to accelerate and derisk product development in the niche field of OINDP. For more information, visit www.nanopharm.co.uk and www.aptar.com.

This press release contains forward-looking statements, including the potential outcomes of the SmartTrack™ technology. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts and by use of words such as “expects,” “anticipates,” “believes,” “estimates,” “future,” “potential,” “continues” and other similar expressions or future or conditional verbs such as “will,” “should,” “would” and “could” are intended to identify such forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on our beliefs as well as assumptions made by and information currently available to us. Accordingly, our actual results or other events may differ materially from those expressed or implied in such forward-looking statements due to known or unknown risks and uncertainties that exist in our operations and business environment including, but not limited to: the successful integration of acquisitions; the regulatory environment; and competition, including technological advances. For additional information on these and other risks and uncertainties, please see our filings with the Securities and Exchange Commission, including the discussion under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Form 10-K and Forms 10-Q. We undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as otherwise required by law.

1Abbreviated New Drug Application (ANDA) | FDA

 

Aptar Investor Relations Contact:

Mary Skafidas

[email protected]

+1 347 351 6407

Aptar Pharma Media Contact:

Ciara Jackson

[email protected]

+49 151 1951 6502

KEYWORDS: United States North America Illinois

INDUSTRY KEYWORDS: Professional Services Health Data Analytics Health Technology Clinical Trials Pharmaceutical

MEDIA:

Photo
Photo
Nanopharm’s SmartTrack™ for Generic Inhalation Products
Logo
Logo

Ecolab Announces 5% Trade Surcharge in the United States

Ecolab Announces 5% Trade Surcharge in the United States

ST. PAUL, Minn.–(BUSINESS WIRE)–
Ecolab Inc. announced today a 5% trade surcharge on all of its solutions and services in the United States, effective May 1, 2025. This surcharge is intended to mitigate the impact of rising raw material costs due to recent changes in international trade policies. With the implementation of this surcharge, Ecolab’s focus remains on delivering value that exceeds the total price increase, helping to offset the impact for customers.

Christophe Beck, Ecolab’s chairman and chief executive officer, said, “At Ecolab, our customers are our priority, and we are committed to delivering exceptional value and best-in-class outcomes, no matter the circumstances. Our robust and agile global supply chain is a competitive advantage that sets us apart in the marketplace. Through our ‘local for local’ model, we’ve strategically positioned ourselves to ensure that more than 90% of our sales are produced close to our customers, allowing us to effectively navigate challenges like this with confidence.

“We are leveraging the strength of Ecolab to mitigate the impact of the 10% global baseline tariff. However, global tariffs greater than 10% and the 145% tariff placed on China are having broader impacts on the cost of some raw materials, packaging, and equipment. We cannot fully mitigate these increases, necessitating adjustments in our pricing. Because of the proactive actions we have taken in our supply chain, we are currently able to limit the price increase to 5% for our customers in the United States. This surcharge supports our commitment to reliable product supply and allows us to continue to invest in the areas that help us deliver the best outcomes for our customers. We will continue to monitor the situation closely and stand ready to take decisive, market-driven action to adjust the surcharge accordingly.

“For more than a century, Ecolab has been a steadfast partner to our customers in their time of need. Through our proactive actions, we are confident in our ability to deliver exceptional total value to customers and superior returns for shareholders in 2025 and beyond.”

About Ecolab

A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. Building on more than a century of innovation, Ecolab has annual sales of $16 billion, employs approximately 48,000 associates and operates in more than 170 countries around the world. The company delivers comprehensive science-based solutions, data-driven insights and world-class service to advance food safety, maintain clean and safe environments, and optimize water and energy use. Ecolab’s innovative solutions improve operational efficiencies and sustainability for customers in the food, healthcare, high tech, life sciences, hospitality and industrial markets. www.ecolab.com

Follow us on LinkedIn @Ecolab, Instagram @Ecolab_Inc and Facebook @Ecolab.

(ECL-C)

Investor Contacts:

Andrew C. Hedberg

+1 651 250 2185

Cairn Clark

+1 651 250 2291

KEYWORDS: United States North America Minnesota

INDUSTRY KEYWORDS: Medical Supplies Retail Health Restaurant/Bar Utilities Energy Food/Beverage

MEDIA:

Logo
Logo

Western Asset Global High Income Fund Inc. Announces Financial Position as of February 28, 2025

Western Asset Global High Income Fund Inc. Announces Financial Position as of February 28, 2025

NEW YORK–(BUSINESS WIRE)–
Western Asset Global High Income Fund Inc. (NYSE: EHI) today announced the financial position of the Fund as of February 28, 2025.

Current Q Previous Q Prior Yr Q
February 28, 2025 November 30, 2024 February 29, 2024
Total Assets (a)

$

311,772,593

 

$

308,192,491

 

*

$

247,870,031

 

Total Net Assets (a)

$

210,705,627

 

$

213,445,572

 

*

$

167,374,937

 

NAV Per Share of Common Stock (b)

$

6.95

 

$

7.04

 

$

7.37

 

Market Price Per Share

$

6.74

 

$

6.73

 

$

7.08

 

Premium / (Discount)

 

(3.02

)%

 

(4.40

)%

 

(3.93

)%

Outstanding Shares

 

30,299,742

 

 

30,299,742

 

*

 

22,724,807

 

 
Total Net Investment Income (c)

$

3,946,069

 

$

3,538,452

 

$

3,428,710

 

Total Net Realized/Unrealized Gain/(Loss) (c)

$

(323,068

)

$

302,404

 

$

5,682,619

 

Net Increase (Decrease) in Net Assets From Operations (c)

$

3,623,001

 

$

3,840,856

 

$

9,111,329

 

 
Earnings per Common Share Outstanding
Total Net Investment Income (c)

$

0.13

 

$

0.12

 

$

0.15

 

Total Net Realized/Unrealized Gain/(Loss) (c)

$

(0.01

)

$

0.01

 

$

0.25

 

Net Increase (Decrease) in Net Assets From Operations (c)

$

0.12

 

$

0.13

 

$

0.40

 

 
Undistributed/(Overdistributed) Net Investment Income (d)

$

(7,882,561

)

$

(5,465,684

)

$

(5,187,688

)

Undistributed/(Overdistributed) Net Investment Income
Per Share (d)

$

(0.26

)

$

(0.18

)

$

(0.23

)

 
Loan Outstanding (d)

$

75,000,000

 

$

70,000,000

 

$

70,000,000

 

Reverse Repurchase Agreements (d)

$

17,910,994

 

$

18,300,102

 

$

4,946,919

 

Footnotes:

(a)

 

The difference between total assets and total net assets is due primarily to the Fund’s use of borrowings; total net assets do not include borrowings.

(b)

 

NAVs are calculated as of the close of business on the last business day in the periods indicated above.

(c)

 

For the quarter indicated.

(d)

 

As of the date indicated above.

*

 

On October 8, 2024, Western Asset Global High Income Fund Inc. issued 7,574,935 common shares with a subscription price of $6.60 per share, equal to 90.0% of Fund`s net asset value per share of common stock at the close of trading on NYSE on October 8, 2024.

This financial data is unaudited.

The Fund files its semi-annual and annual reports with the Securities and Exchange Commission (“SEC”), as well as its complete schedule of portfolio holdings for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT. These reports are available on the SEC’s website at www.sec.gov. To obtain information on Forms N-PORT or a semi-annual or annual report from the Fund, shareholders can call 1-888-777-0102.

Western Asset Global High Income Fund Inc., a non-diversified, closed-end management investment company, is advised by Franklin Templeton Fund Advisor, LLC (“FTFA”) and is sub-advised by Western Asset Management Company (“Western Asset”). FTFA and Western Asset are indirect, wholly-owned subsidiaries of Franklin Resources, Inc. (“Franklin Resources”).

For more information about the Fund, please call 1-888-777-0102 or consult the Fund’s web site at www.franklintempleton.com/investments/options/closed-end-funds. Hard copies of the Fund’s complete audited financial statements are available free of charge upon request.

Data and commentary provided in this press release are for informational purposes only. Franklin Resources and its affiliates do not engage in selling shares of the Fund.

Category: Financials

Source: Franklin Resources, Inc.

Source: Legg Mason Closed End Funds

Investor Contact: Fund Investor Services 1-888-777-0102

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Asset Management Professional Services Finance

MEDIA:

Acadia Healthcare Announces Date for First Quarter 2025 Earnings Release

Acadia Healthcare Announces Date for First Quarter 2025 Earnings Release

FRANKLIN, Tenn.–(BUSINESS WIRE)–
Acadia Healthcare (NASDAQ: ACHC) (“Acadia” or the “Company”) today announced that it will release its first quarter 2025 financial results on Monday, May 12, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts on Tuesday, May 13, 2025, at 8:30 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website. The webcast of the conference call will be available for 30 days.

The Company also announced that on April 18, 2025, Heather Dixon, the Company’s Chief Financial Officer, will take a brief medical leave to recover from a planned medical procedure. During Ms. Dixon’s brief absence, the Company’s senior finance leadership team, in conjunction with executive management, will oversee Ms. Dixon’s day-to-day responsibilities. The Company currently expects Ms. Dixon to participate in the May 13 conference call.

About Acadia Healthcare

Acadia is a leading provider of behavioral healthcare services across the United States. As of December 31, 2024, Acadia operated a network of 262 behavioral healthcare facilities with approximately 11,850 beds in 39 states and Puerto Rico. With approximately 25,500 employees serving more than 80,000 patients daily, Acadia is the largest stand-alone behavioral healthcare company in the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.

Patrick Feeley

Senior Vice President, Investor Relations

(615) 861-6000

KEYWORDS: United States North America Tennessee

INDUSTRY KEYWORDS: Mental Health Health Infectious Diseases Physical Therapy Managed Care General Health Vitamins/Supplements

MEDIA:

Logo
Logo

UNICSKIN Integrates Perfect Corp.’s AI Skin Analysis to Personalize LED Mask Recommendations Online

UNICSKIN Integrates Perfect Corp.’s AI Skin Analysis to Personalize LED Mask Recommendations Online

AI-Powered Skin Analysis Helps Beauty Shoppers Identify the Right LED Light Therapy Based on Their Real-Time Skin Needs.

NEW YORK–(BUSINESS WIRE)–Perfect Corp. (NYSE: PERF), a global leader in augmented reality (AR) and artificial intelligence (AI) beauty and fashion tech, has teamed up with Spanish Techno-Beauty brand UNICSKIN to enhance the online skincare experience through advanced AI-powered skin assessments. The integration brings Perfect Corp.’s AI Skin Analysis technology to UNICSKIN’s e-commerce platform, offering shoppers personalized LED mask recommendations based on their real-time skin condition.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250416738551/en/

UNICSKIN Integrates Perfect Corp.’s AI Skin Analysis to Personalize LED Mask Recommendations Online

UNICSKIN Integrates Perfect Corp.’s AI Skin Analysis to Personalize LED Mask Recommendations Online

The technology analyzes four key skin metrics—wrinkles, firmness, acne, and dark spots—to determine the ideal LED light color for each user’s specific concerns. For example, red light is recommended for its anti-aging effects, which help reduce wrinkles and improve firmness, while blue light is suggested for acne-prone skin. The result is a hyper-personalized skincare journey that helps users choose the right treatment from UNICSKIN’s new LED mask collection with greater confidence and clarity.

From Skin Insights to Light Therapy: Scaling AI Across the Skincare Journey

Perfect Corp.’s AI Skin Analysis was first launched on UNICSKIN’s website through the “InstaSkin Pro” tool, which delivers product recommendations for serums, creams, and other skincare solutions. Building on the success of that feature, UNICSKIN has now added a dedicated AI-powered experience specifically tailored for its LED mask lineup: the InstaSkin Pro 5.0, further strengthening its commitment to precision skincare through technology.

Frictionless E-Commerce Shopping Experience, Powered by AI

The solution is enabled through Perfect Corp.’s AI Skin Analysis Widget Mode that allows for rapid deployment with minimal technical overhead. The AI Widget Mode’s Plug & Play access, available through Perfect Corp’s Console, delivers a ready-to-use UI and UX experience, along with simplified customization. This generates an instant skin assessment and a customized product routine that adapts to each user’s needs.

With this implementation, UNICSKIN empowers consumers to make more informed skincare decisions through real-time skin insights, while streamlining product discovery in a fast-growing segment of at-home beauty tech.

Turning Data Into Beauty Decisions for At-Home Skincare Innovation

“As skincare continues to evolve, consumers are embracing a wide range of solutions—from serums and creams to innovative beauty devices,” said Alice Chang, Founder and CEO of Perfect Corp. “We’re proud to see our AI Skin Analysis technology supporting this shift by extending into new categories such as LED masks. It’s also a pleasure to continue growing our collaboration with UNICSKIN, following the success of our initial work together on InstaSkin Pro.”

Mónica Sada, CEO & Founder at UNICSKIN, added, “At UNICSKIN, we’re always looking for ways to combine science and innovation to elevate our customers’ skincare journey. By integrating Perfect Corp.’s AI skin analysis, we can now provide even more accurate LED mask guidance tailored to individual needs.”

On-Pack AI Activation: Driving Real-Time Engagement from Shelf to Screen

To celebrate the launch of its new LED mask collection, UNICSKIN hosted an exclusive event on April 9. As part of the experience, guests were able to access a personalized skin analysis via QR codes printed on the product packaging—offering an optional digital touchpoint that connects users to tailored LED mask recommendations.

Experience the AI-powered LED mask recommendation tool at:

https://unicskin.com/pages/instaskin-pro-skin-diagnosis-centurion-5-0

Learn more about Perfect Corp.’s AI Skin Analysis technology:

https://www.perfectcorp.com/business/products/ai-skin-diagnostic

About Unicskin

Other companies move the gym, hair salon or restaurant. UNICSKIN brings the beauty cabin to your home and your travels.

Efficiency and immediate results are the common denominator of all our products. Because UNICSKIN’s motto is that if there are no results, it’s not worth it. Furthermore, all formulas come from more than 92% natural origin and the company is fully committed to sustainability in its packaging and supply chain processes. Being a Spanish brand, the Middle East became our first success story, where Arab women fell in love with UNICSKIN. We now sell in over 30 countries and export over 85% of our sales.

About Perfect Corp.

Founded in 2015, Perfect Corp. (NYSE: PERF) is on a mission to make beauty smarter, more personalized, and more fun through Beautiful AI. As a global leader in AI and AR-powered beauty and fashion technology, we help brands and consumers connect through immersive, interactive digital experiences.

With cutting-edge AI solutions, Perfect Corp. powers iconic virtual try-ons across makeup, hairstyles, eyewear, jewelry, watches, and fashion accessories, along with advanced AI-driven analyzers for skin and hair that provide real-time insights for personalized recommendations. Our generative AI tools take creativity to the next level, offering photo and video editing, AI content generation, and personalized beauty experiences.

Trusted by over 705 global brands and 1.1 billion YouCam app downloads, we make beauty, fashion, and skincare more accessible, engaging, and intuitive than ever before.

Press Contacts

Perfect Corp. official website: https://www.perfectcorp.com/

Perfect Corp. on LinkedIn: https://www.linkedin.com/company/perfect-corp/

Perfect Corp. official Blog: https://www.perfectcorp.com/business/blog

Corporate: Tony Tsai at [email protected] or by phone: +886-2-8667-1265, ext. 2167

USA: Allie Murphy at [email protected] or by phone +1 (415) 625-8555

Japan: Kazushige Sato at [email protected] or by phone: +81-3-5875-6651

China: Winter Zhang at [email protected] or by phone: +86-166-2139-1855

Europe: Pauline Griffon at [email protected]

UAE: Marwa Mohamed at [email protected] or by phone: +971 (0) 50-728-4178

India: Taunj Mishra at [email protected]

Indonesia: Efon Dea at [email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Luxury Bridal Technology Department Stores General Health Health Apps/Applications Fashion Cosmetics Software Retail Internet Hardware Consumer Electronics Online Retail Catalog Artificial Intelligence

MEDIA:

Photo
Photo
UNICSKIN Integrates Perfect Corp.’s AI Skin Analysis to Personalize LED Mask Recommendations Online
Logo
Logo

Average U.S. FICO Score Drops to 715

Average U.S. FICO Score Drops to 715

FICO analysis shows that more than eight million borrowers are potentially impacted by new student loan delinquencies, partly driving the two point drop of the average U.S. FICO® Score

BOZEMAN, Mont.–(BUSINESS WIRE)–
Global analytics software leader FICO (NYSE: FICO), today announced that the national average U.S. FICO® Score stands at 715. This marks a decline of one point from January 2025 and a two-point drop from April 2024, partly driven by the resumption of federal student loan delinquency reporting on U.S. consumers’ credit.

FICO® Scores power lending decisions for 90% of the top U.S. lenders, serving as the go-to benchmark for assessing consumer credit risk. As consumer behavior shifts, FICO Scores reflect these changes through data reported by the three main credit bureaus. FICO publishes the national average score on a regular basis, providing a pulse on the state of consumer credit in the United States.

“FICO remains committed to providing the industry with reliable, independent insights that help lenders make informed decisions and empower consumers to understand and manage their credit,” said Tommy Lee, senior director of Scores and Predictive Analytics at FICO. “The modest decline in the national average FICO Score is consistent with the anticipated effects of resuming student loan delinquency reporting. As we move through 2025, we’ll continue to monitor how consumers navigate the post-forbearance credit environment as well as the ongoing economic uncertainty.”

Key factors impacting the average U.S. FICO® Score in 2025:

  • Resumption of Student Loan Reporting: Following a multi-year pause under the CARES Act and a one-year “on-ramp” grace period by the Department of Education, as of February 2025 federal student loan delinquencies are once again reported on credit files.
  • Rising Delinquencies: The share of consumers with a 90+ day delinquency in the past six months increased from 7.4% in January to 8.3% in February—a 12% relative rise, and the first time this figure has surpassed pre-pandemic levels (8.1% in January 2020).
  • Credit Utilization Decreasing: Despite the rise in delinquencies, some consumers experienced modest improvements in credit utilization—a key metric representing 30% of the FICO® Score. Average credit card utilization decreased from January to February due to seasonal reductions in credit card balances following holiday spending, helping to partially offset the score decline.

Full analysis on the average U.S. FICO® Score is available here: https://www.fico.com/blogs/student-loan-delinquencies-lower-average-fico-score-715

About FICO

FICO (NYSE: FICO) powers decisions that help people and businesses around the world prosper. Founded in 1956, the company is a pioneer in the use of predictive analytics and data science to improve operational decisions. FICO holds more than 200 US and foreign patents on technologies that increase profitability, customer satisfaction and growth for businesses in financial services, insurance, telecommunications, health care, retail and many other industries. Using FICO solutions, businesses in more than 80 countries do everything from protecting 4 billion payment cards from fraud, to improving financial inclusion, to increasing supply chain resiliency. The FICO® Score, used by 90% of top US lenders, is the standard measure of consumer credit risk in the US and has been made available in over 40 other countries, improving risk management, credit access and transparency.

Learn more at https://www.fico.com/en.

Join the conversation at https://x.com/FICO_corp & https://www.fico.com/blogs/.

For FICO news and media resources, visit https://www.fico.com/en/newsroom.

FICO is a registered trademark of Fair Isaac Corporation in the U.S. and other countries.

FICO Contact

Julie Huang

[email protected]

KEYWORDS: United States North America Montana

INDUSTRY KEYWORDS: Technology Personal Finance Payments Finance Banking Professional Services Software Data Analytics Data Management

MEDIA:

Logo
Logo